Flumazenil for the Treatment of Primary Hypersomnia

NCT01183312 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Hypersomnia
Primary Hypersomnia
Idiopathic Hypersomnia
Narcolepsy Without Cataplexy

Interventions

DRUG: Flumazenil

Sponsor

Lynn Marie Trotti

Collaborators

[object Object]